Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ritonavir/adverse effects"'
Autor:
Lorenzo Alberio, Grégoire Stalder
Publikováno v:
Blood, vol. 136, no. 7, pp. 915
Blood
Blood
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c438e4f5a38725512ab71b2da7907ae
https://serval.unil.ch/resource/serval:BIB_4B348B262495.P001/REF.pdf
https://serval.unil.ch/resource/serval:BIB_4B348B262495.P001/REF.pdf
Autor:
Rudin, Christoph, Wolbers, Marcel, Nadal, David, Rickenbach, Martin, Bucher, Heiner C, the Pediatric Infectious Disease Group of Switzerland (PIGS), the Swiss Mother and Child HIV Cohort Study (MoCHiV)
Publikováno v:
Archives of Disease in Childhood, Vol. 95, No 6 (2010) pp. 478-81
AIM: To evaluate the long-term safety and effectiveness of lopinavir/ritonavir (LPV/r) in a population-based cohort of HIV-1-infected children. METHODS: All children enrolled in the Swiss Mother and Child HIV Cohort Study, treated with LPV/r-based co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05fc413a7b44baad66da346e3eb97c77
https://doi.org/10.1136/adc.2009.169375
https://doi.org/10.1136/adc.2009.169375
Autor:
Martin Rickenbach, S De Wit, Silvia Mateu, M Dupon, Kathy Petoumenos, Jens D Lundgren, Peter Reiss, A d'Arminio Monforte, Caroline A. Sabin, Eric Fontas, Nina Friis-Møller, Wafaa El-Sadr, Ole Kirk, Christian Pradier, Linda Morfeldt, F. Van Leth
Publikováno v:
Journal of Infectious Diseases, vol. 189, no. 6, pp. 1056-74
Journal of infectious diseases, 189(6), 1056-1074. Oxford University Press
The Journal of Infectious Diseases, 189(6), 1056-1074. Oxford University Press
Journal of infectious diseases, 189(6), 1056-1074. Oxford University Press
The Journal of Infectious Diseases, 189(6), 1056-1074. Oxford University Press
Levels of triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-c), and high-density lipoprotein cholesterol (HDL-c), as well as the TC:HDL-c ratio, were compared in patients receiving different antiretroviral therapy r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19f4b7765ac19218972004f87ee55876
https://doi.org/10.1086/381783
https://doi.org/10.1086/381783
Autor:
Jinell Mah Ming, Yaping Chang, Yung Lee, Arnav Agarwal, Farid Foroutan, Elliot Hepworth, Reed A C Siemieniuk, Yuan Zhang, Dena Zeraatkar, Paul E. Alexander, Arnaud Merglen, Reza Mirza, Hassan Mir, Olufunmilayo A. Lesi, Gordon H. Guyatt
Publikováno v:
BMJ Open, Vol. 7, No 9 (2017) P. e019022
BMJ Open
BMJ Open
ObjectiveTo assess the impact of various antiretroviral/antiviral regimens in pregnant women living with HIV or hepatitis B virus (HBV).DesignWe performed random effects meta-analysis for HIV-related outcomes and network meta-analysis for HBV outcome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e44976e50c7871be57fdb741db5d080
https://doi.org/10.1136/bmjopen-2017-019022
https://doi.org/10.1136/bmjopen-2017-019022
Autor:
Jim, Young, Juliane, Schäfer, Christoph A, Fux, Hansjakob, Furrer, Enos, Bernasconi, Pietro, Vernazza, Alexandra, Calmy, Matthias, Cavassini, Rainer, Weber, Manuel, Battegay, Heiner C, Bucher, S, Yerly
Publikováno v:
AIDS, Vol. 26, No 5 (2012) pp. 567-75
Background: Tenofovir is associated with reduced renal function, but it is not clear whether there is a greater decline in renal function when tenofovir is co-administered with a boosted protease inhibitor rather than with a nonnucleoside reverse tra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89773cafd0a6a8e5115793d5ddc0d632
https://pubmed.ncbi.nlm.nih.gov/22398568
https://pubmed.ncbi.nlm.nih.gov/22398568
Publikováno v:
Archivos de Pediatría del Uruguay, Volume: 83, Issue: 1, Pages: 21-25, Published: MAR 2012
Resumen Se presentan tres casos clínicos de niños con infección por el virus de la inmunodeficiencia humana (en tratamiento con ritonavir/lopinavir, zidovudina y lamivudina) y asma persistente y/o rinitis alérgica (en tratamiento con propionato d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______615::fb250231d7854709a345bac9c3ac73b9
http://www.scielo.edu.uy/scielo.php?script=sci_arttext&pid=S1688-12492012000100005&lng=en&tlng=en
http://www.scielo.edu.uy/scielo.php?script=sci_arttext&pid=S1688-12492012000100005&lng=en&tlng=en
Publikováno v:
Pediatric Infectious Disease Journal, Vol. 27, No 5 (2008) pp. 431-437
AIM: To evaluate the long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced, initially protease inhibitor (PI)-naive, human immunodeficiency virus (HIV)-1-infected children. METHODS: HIV-1-i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ed44aa9e81459e106d0166b94530dd2
Autor:
P, Lorenzi, S, Yerly, K, Abderrakim, M, Fathi, O T, Rutschmann, J, von Overbeck, D, Leduc, L, Perrin, B, Hirschel
Publikováno v:
AIDS, Vol. 11, No 12 (1997) pp. F95-99
OBJECTIVE: To assess the safety, efficacy and plasma drug levels of the combination of ritonavir plus saquinavir for the treatment of advanced HIV infection. DESIGN: Multicentre pilot study. PATIENTS: Eighteen protease inhibitor-naive patients, with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::db81020713b06ecf3ccc869de7bad723
https://archive-ouverte.unige.ch/unige:7419
https://archive-ouverte.unige.ch/unige:7419
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.